首页> 外文期刊>Xenobiotica: the fate of foreign compounds in biological systems >Development of a pharmacokinetic/pharmacodynamic/disease progression model in NC/Nga mice for development of novel anti-atopic dermatitis drugs
【24h】

Development of a pharmacokinetic/pharmacodynamic/disease progression model in NC/Nga mice for development of novel anti-atopic dermatitis drugs

机译:新型抗特应性皮肤膜炎症的NC / NGA小鼠药代动力学/药物动力学/疾病进展模型的研制

获取原文
获取原文并翻译 | 示例
           

摘要

1. JHL45, a novel immune modulator against atopic dermatitis (AD), was synthesized from decursin isolated from Angelica gigas. The goal is to evaluate the lead compound using quantitative modeling approaches to novel anti-AD drug development.
机译:1. JHL45是一种针对特征性皮炎(AD)的新型免疫调节剂,由来自Angelica Gigas分离的Decsin合成。 目标是使用定量建模方法来评估铅化合物,以新颖的抗AD药物发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号